124 related articles for article (PubMed ID: 31728055)
1. Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML.
Ren Z; Shrestha M; Sakamoto T; Melkman T; Meng L; Cairns RA; Zacksenhaus E; Mak TW; Stambolic V; Minden MD; Wang JA
Leukemia; 2020 Apr; 34(4):1172-1176. PubMed ID: 31728055
[No Abstract] [Full Text] [Related]
2. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M
Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403
[TBL] [Abstract][Full Text] [Related]
3. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
4. NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemia.
Wang AJ; Han Y; Jia N; Chen P; Minden MD
Leukemia; 2020 May; 34(5):1278-1290. PubMed ID: 31831844
[TBL] [Abstract][Full Text] [Related]
5. EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.
Skayneh H; Jishi B; Hleihel R; Hamie M; El Hajj R; Deleuze-Masquefa C; Bonnet PA; El Sabban M; El Hajj H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408798
[TBL] [Abstract][Full Text] [Related]
6. Proteostasis unbalance of nucleophosmin 1 in Acute Myeloid Leukemia: An aggregomic perspective.
Di Natale C; Florio D; Di Somma S; Di Matteo A; Federici L; Netti PA; Morelli G; Malfitano AM; Marasco D
Int J Biol Macromol; 2020 Dec; 164():3501-3507. PubMed ID: 32890557
[TBL] [Abstract][Full Text] [Related]
7. When the good go bad: Mutant NPM1 in acute myeloid leukemia.
Kunchala P; Kuravi S; Jensen R; McGuirk J; Balusu R
Blood Rev; 2018 May; 32(3):167-183. PubMed ID: 29157973
[TBL] [Abstract][Full Text] [Related]
8. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
[TBL] [Abstract][Full Text] [Related]
9. The acute myeloid leukemia-associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain.
La Manna S; Scognamiglio PL; Roviello V; Borbone F; Florio D; Di Natale C; Bigi A; Cecchi C; Cascella R; Giannini C; Sibillano T; Novellino E; Marasco D
FEBS J; 2019 Jun; 286(12):2311-2328. PubMed ID: 30921500
[TBL] [Abstract][Full Text] [Related]
10. Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
Vascotto C; Lirussi L; Poletto M; Tiribelli M; Damiani D; Fabbro D; Damante G; Demple B; Colombo E; Tell G
Oncogene; 2014 May; 33(22):2876-87. PubMed ID: 23831574
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML.
Issa GC; Bidikian A; Venugopal S; Konopleva M; DiNardo CD; Kadia TM; Borthakur G; Jabbour E; Pemmaraju N; Yilmaz M; Short NJ; Maiti A; Sasaki K; Masarova L; Pierce S; Takahashi K; Tang G; Loghavi S; Patel K; Andreeff M; Bhalla K; Garcia-Manero G; Ravandi F; Kantarjian H; Daver N
Blood Adv; 2023 Mar; 7(6):933-942. PubMed ID: 36322818
[TBL] [Abstract][Full Text] [Related]
12. Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor.
Nemeckova S; Alexova-Zurkova K; Hainz P; Krystofova J; Mackova J; Roubalova K; Stastna-Markova M; Vrana M; Vydra J
Curr Oncol; 2022 Apr; 29(5):2928-2934. PubMed ID: 35621629
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
14. Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
Xian J; Shao H; Chen X; Zhang S; Quan J; Zou Q; Jin H; Zhang L
Int J Biol Sci; 2016; 12(2):144-55. PubMed ID: 26884713
[TBL] [Abstract][Full Text] [Related]
15. Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia.
Sakthivel D; Brown-Suedel AN; Keane F; Huang S; Sherry KM; Charendoff CI; Dunne KP; Robichaux DJ; Le B; Shin CS; Carisey AF; Flanagan JM; Bouchier-Hayes L
bioRxiv; 2023 May; ():. PubMed ID: 37398413
[TBL] [Abstract][Full Text] [Related]
16. Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells.
Ghasemi R; Struthers H; Wilson ER; Spencer DH
Leukemia; 2021 Feb; 35(2):404-416. PubMed ID: 32398790
[TBL] [Abstract][Full Text] [Related]
17. Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia.
Uckelmann HJ; Haarer EL; Takeda R; Wong EM; Hatton C; Marinaccio C; Perner F; Rajput M; Antonissen NJC; Wen Y; Yang L; Brunetti L; Chen CW; Armstrong SA
Cancer Discov; 2023 Mar; 13(3):746-765. PubMed ID: 36455613
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
19. Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.
Wu HC; Rérolle D; Berthier C; Hleihel R; Sakamoto T; Quentin S; Benhenda S; Morganti C; Wu C; Conte L; Rimsky S; Sebert M; Clappier E; Souquere S; Gachet S; Soulier J; Durand S; Trowbridge JJ; Bénit P; Rustin P; El Hajj H; Raffoux E; Ades L; Itzykson R; Dombret H; Fenaux P; Espeli O; Kroemer G; Brunetti L; Mak TW; Lallemand-Breitenbach V; Bazarbachi A; Falini B; Ito K; Martelli MP; de Thé H
Cancer Discov; 2021 Dec; 11(12):3198-3213. PubMed ID: 34301789
[TBL] [Abstract][Full Text] [Related]
20. Nuclear accumulation of SHIP1 mutants derived from AML patients leads to increased proliferation of leukemic cells.
Nalaskowski MM; Ehm P; Rehbach C; Nelson N; Täger M; Modest K; Jücker M
Cell Signal; 2018 Sep; 49():87-94. PubMed ID: 29852247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
